Concepedia

Ivan Rychlík

IR

100

Publications

6.6K

Citations

38

H-Index

1959

Active since

Affiliations

Charles University(Current)

Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry

University Medical Center Groningen

University of Groningen

University of Glasgow

Ivan Rychlík is an author at Charles University specializing in medicine, natural sciences, and biochemistry.

ORCID

Top concepts

Publications per year

1959–2025

100

Publications

100

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

, , +7

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

Alberto Ortíz, Mario Cozzolino, Danilo Fliser et al. · Nephrology Dialysis Transplantation · 2020 · 363 citations · Full text

Carnosine as a Protective Factor in Diabetic Nephropathy

Bart Janssen, Daniela Hohenadel, Paul T. Brinkkoetter et al. · Diabetes · 2005 · 283 citations · Full text

, , +15

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 264 citations

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Joost P. Schanstra, Petra Zürbig, Alaa Alkhalaf et al. · Journal of the American Society of Nephrology · 2015 · 248 citations · Full text

Rows per page

1–5 of 100